Blog Symposia From Principles to Practice: Human Rights and Public Health Emergencies Global Health Global Health and Rights Project Human Rights International Pharmaceuticals Public Health Resource Allocation
Intellectual Property
-
-
Blog Symposia Climate Change From Principles to Practice: Human Rights and Public Health Emergencies Global Health Global Health and Rights Project Health Law Policy Human Rights Immunization Intellectual Property International Pharmaceuticals Public Health Resource AllocationMaking Explicit a Rights-Based Approach to Infodemic in a Public Health Emergency
Read more: Making Explicit a Rights-Based Approach to Infodemic in a Public Health Emergency -
Blog Symposia Climate Change From Principles to Practice: Human Rights and Public Health Emergencies Global Health Global Health and Rights Project Health Law Policy Human Rights Immunization Intellectual Property International Pharmaceuticals Public Health Resource AllocationCOVID-19 Showcased Failed Global Cooperation
Read more: COVID-19 Showcased Failed Global Cooperation -
Alicia Ely Yamin Blog Symposia Climate Change Featured From Principles to Practice: Human Rights and Public Health Emergencies Global Health Global Health and Rights Project Health Law Policy Human Rights Immunization Intellectual Property International Pharmaceuticals Public Health Resource AllocationIntroduction to the Symposium: From Principles to Practice: Human Rights and Public Health Emergencies
Read more: Introduction to the Symposium: From Principles to Practice: Human Rights and Public Health Emergencies -
Biotechnology Featured Health Law Policy Intellectual Property International Pharmaceuticals Public Health Resource Allocation VaccinesWhat the New York City Marathon Can Teach Us About Equitable Access to Vaccines
Read more: What the New York City Marathon Can Teach Us About Equitable Access to Vaccines -
Aparajita Lath Immunization Intellectual Property Pharmaceuticals Public Health Student Fellows VaccinesIs Messenger RNA Patent-Eligible?
Read more: Is Messenger RNA Patent-Eligible? -
Aparajita Lath Global Health Health Law Policy Intellectual Property Market Design Pharmaceuticals Public Health Reimbursement Resource Allocation Student Fellows VaccinesUnlocking the mRNA Platform Technology: Walking the Talk with Investment Protection
Read more: Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection -
Visualizing the Growing Intersection of Life Sciences and Computing Patents in the US from 1976-2021
Read more: Visualizing the Growing Intersection of Life Sciences and Computing Patents in the US from 1976-2021 -
Biotechnology Global Health Intellectual Property International Pharmaceuticals Public Health Race Resource Allocation Sarah Gabriele Student Fellows Vaccines
Biotech Companies Are Opening Manufacturing Sites in Africa: Will This Help Vaccine Equity?
Read more: Biotech Companies Are Opening Manufacturing Sites in Africa: Will This Help Vaccine Equity? -
Aparajita Lath Immunization Intellectual Property Pharmaceuticals Public Health Student Fellows VaccinesCOVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues
Read more: COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues